Case Reports And What A Single Patient Can Establish

A large share of the published literature on traditional medicines consists of case reports describing single patients. That design can establish some things firmly and others not at all.

What a case report is

A case report is a detailed account of one patient's presentation, treatment and course, written up because something about it was considered noteworthy.

A case series extends this to a handful of similar patients, still without a comparison group and still selected because they were interesting.

Neither design involves randomisation, blinding or controls, which places them at the lowest tier of most evidence hierarchies.

What they establish well

Case reports are strong at demonstrating that something can happen, and a single well-documented instance is enough to establish possibility.

They are the primary route by which rare adverse effects are first identified, particularly effects too uncommon to appear in a trial of ordinary size.

They also supply detail that aggregate studies lose, including timing, dose, concurrent medications and the course after a suspected agent was stopped.

What they cannot establish

A case report cannot show that a treatment works, because the natural course of the condition and the effects of everything else the patient was doing are unaccounted for.

Many conditions improve on their own, and a report describing improvement after a treatment cannot separate the two possibilities in a single person.

Selection is the deeper problem. Cases are written up because they were remarkable, so the published set is by definition unrepresentative.

Why the asymmetry favours harm reports

Establishing that a substance can cause harm requires showing a plausible link in one person, which a detailed case can do, especially with a positive rechallenge.

Establishing benefit requires ruling out the alternatives, which needs a comparison group and cannot be done from a single course of events.

This is why case reports carry real weight in safety literature on herbal products and very little weight in efficacy claims for the same products.

How this shapes the Ayurvedic literature

A substantial portion of published Ayurvedic clinical writing consists of cases treated in classical fashion and reported as successes.

Such reports document how practice is actually conducted, which is genuinely useful, and they should not be cited as evidence that the treatment worked.

Anyone weighing a treatment for a serious condition needs trial evidence and a physician, not a collection of published individual outcomes.